B7/BB-1 antigen expression on adult human microglia studiedin vitro andin situ

1994 ◽  
Vol 24 (12) ◽  
pp. 3031-3037 ◽  
Author(s):  
Kenneth Williams ◽  
Elling Ulvestad ◽  
Jack P. Antel
2016 ◽  
Vol 54 (3) ◽  
pp. 1157-1167 ◽  
Author(s):  
Ling Guo ◽  
Aras Rezvanian ◽  
Lokesh Kukreja ◽  
Ramez Hoveydai ◽  
Eileen H. Bigio ◽  
...  

2003 ◽  
Vol 105 (2) ◽  
pp. 135-144 ◽  
Author(s):  
Robert Veerhuis ◽  
Mariëlle J. Van Breemen ◽  
Jeroen J. Hoozemans ◽  
Michela Morbin ◽  
Jamal Ouladhadj ◽  
...  

Author(s):  
Ishan Agrawal ◽  
Shivanjali Saxena ◽  
Preethika Nair ◽  
Deepak Jha ◽  
Sushmita Jha

1992 ◽  
Vol 51 (5) ◽  
pp. 538-549 ◽  
Author(s):  
Kenneth Williams ◽  
Amit Bar-Or ◽  
Elling Ulvestad ◽  
Andre Olivier ◽  
Jack P. Antel ◽  
...  

2020 ◽  
Vol 117 (28) ◽  
pp. 16475-16480 ◽  
Author(s):  
Irene Tsilioni ◽  
Harry Pantazopoulos ◽  
Pio Conti ◽  
Susan E. Leeman ◽  
Theoharis C. Theoharides

Autism spectrum disorder (ASD) is characterized by impaired social interactions and communication. The pathogenesis of ASD is not known, but it involves activation of microglia. We had shown that the peptide neurotensin (NT) is increased in the serum of children with ASD and stimulates cultured adult human microglia to secrete the proinflammatory molecules IL-1β and CXCL8. This process is inhibited by the cytokine IL-37. Another cytokine, IL-38, has been reported to have antiinflammatory actions. In this report, we show that pretreatment of cultured adult human microglia with recombinant IL-38 (aa3-152, 1–100 ng/mL) inhibits (P< 0.0001) NT-stimulated (10 nM) secretion of IL-1β (at 1 ng/mL) and CXCL8 (at 100 ng/mL). In fact, IL-38 (aa3-152, 1 ng/mL) is more potent than IL-37 (100 ng/mL). Here, we report that pretreatment with IL-38 (100 ng/mL) of embryonic microglia (HMC3), in which secretion of IL-1β was undetectable, inhibits secretion of CXCL8 (P= 0.004). Gene expression of IL-38 and its receptor IL-36R are decreased (P= 0.001 andP= 0.04, respectively) in amygdala from patients with ASD (n= 8) compared to non-ASD controls (n= 8), obtained from the University of Maryland NeuroBioBank. IL-38 is increased (P= 0.03) in the serum of children with ASD. These findings indicate an important role for IL-38 in the inhibition of activation of human microglia, thus supporting its development as a treatment approach for ASD.


1989 ◽  
Vol 23 (1) ◽  
pp. 45-53 ◽  
Author(s):  
Barbara P. Barna ◽  
Samuel M. Chou ◽  
Barbara Jacobs ◽  
Belinda Yen-Lieberman ◽  
Richard M. Ransohoff

1997 ◽  
Vol 17 (11) ◽  
pp. 655-664 ◽  
Author(s):  
ANNA DA CUNHA ◽  
JANE J. JEFFERSON ◽  
WILLIAM R. TYOR ◽  
JONATHAN D. GLASS ◽  
FRANK S. JANNOTTA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document